Download Press Release: Shire Acquires Premacure AB

Lexington, MA, US- March 12, 2013- Shire announces that it has acquired Premacure AB of Uppsala, Sweden, a privately held biotechnology company developing a protein replacement therapy, currently in Phase II development, for the prevention of retinopathy of prematurity (ROP). ROP is a rare and potentially blinding eye disorder that primarily affects premature infants and is one of the most …

Download Press Release: Shire Acquires Lotus Tissue Repair, Inc

Lexington, MA, US- January 8, 2013- Shire announces that it has signed an agreement to acquire Lotus Tissue Repair, Inc. of Cambridge, MA, a privately held biotechnology company developing the first and only protein replacement therapy currently being investigated for the treatment of dystrophic epidermolysis bullosa (DEB). DEB is a devastating orpahn disease for which no currently approved treatment option …